SCOPUS 정보 검색 플랫폼

Volumn 2, Issue 8, 2011, Pages 771-774

Overcoming retinoic acid receptor-α based testicular toxicity in the optimisation of glucokinase activators

(9) Waring, Michael J a Brogan, Iain J a,b Coghlan, Matthew a Johnstone, Craig a,b Jones, Huw B a Leighton, Brendan a McKerrecher, Darren a Pike, Kurt G a Robb, Graeme R a

a ASTRAZENECA (United Kingdom)

b Prosidion Limited (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; GLUCOKINASE ACTIVATOR; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TESTICULAR TOXICITY; TESTIS DISEASE; TOXICITY TESTING;

EID: 79959315409 PISSN: 20402503 EISSN: 20402511 Source Type: Journal
DOI: 10.1039/c1md00090j Document Type: Article

Times cited : (17)

References (17)

1
- 0037340779
- M. Tadayyon S. A. Smith Expert Opin. Invest. Drugs 2003 12 307
- (2003) Expert Opin. Invest. Drugs , vol.12 , pp. 307
- Tadayyon, M.¹ Smith, S.A.²

2
- 0032983666
- R. C. Turner C. A. Cull V. Frighi R. Holmann J. Am. Med. Assoc. 1999 281 2005
- (1999) J. Am. Med. Assoc. , vol.281 , pp. 2005
- Turner, R.C.¹ Cull, C.A.² Frighi, V.³ Holmann, R.⁴

3
- 0036896635
- F. M. Matschinsky Diabetes 2002 51 S394
- (2002) Diabetes , vol.51 , pp. 394
- Matschinsky, F.M.¹

4
- 18044362604
- in, F. M. Matschinsky, M. A. Magnuson, ed. Karger:Basel,;, pp 1-17
- F. M. Matschinsky, M. A. Magnuson, in Frontiers in Diabetes, F. M. Matschinsky, M. A. Magnuson, ed. Karger:Basel, 2004; Vol. 16, pp 1-17
- (2004) Frontiers in Diabetes , vol.16
- Matschinsky, F.M.¹ Magnuson, M.A.²

5
- 20244377376
- A. Gloyn S. Odili D. Zelent C. Buettger H. A. Castleden A. M. Steele A. Stride C. Shiota M. A. Magnuson R. Lorini G. d'Annunzio C. A. Stanley J. Kwagh E. van Schaftingen M. Veigha da Cunha F. Barbetti P. Dunten Y. Han J. Grimsby R. Taub S. Ellard A. T. Hattersley F. M. Matschinsky J. Biol. Chem. 2005 280 14105
- (2005) J. Biol. Chem. , vol.280 , pp. 14105
- Gloyn, A.¹ Odili, S.² Zelent, D.³ Buettger, C.⁴ Castleden, H.A.⁵ Steele, A.M.⁶ Stride, A.⁷ Shiota, C.⁸ Magnuson, M.A.⁹ Lorini, R.¹⁰ D'Annunzio, G.¹¹ Stanley, C.A.¹² Kwagh, J.¹³ Van Schaftingen, E.¹⁴ Veigha Da Cunha, M.¹⁵ Barbetti, F.¹⁶ Dunten, P.¹⁷ Han, Y.¹⁸ Grimsby, J.¹⁹ Taub, R.²⁰ more..

6
- 18044388740
- B. Leighton A. Atkinson M. P. Coghlan Biochem. Soc. Trans. 2005 33 371
- (2005) Biochem. Soc. Trans. , vol.33 , pp. 371
- Leighton, B.¹ Atkinson, A.² Coghlan, M.P.³

7
- 14644394924
- For comprehensive reviews of GKAs see
- D. Zelent H. Najafi S. Odili C. Buettger H. Weik-Collins C. Li N. Doliba J. Grimsby F. M. Matschinsky Biochem. Soc. Trans. 2005 33 306
- (2005) Biochem. Soc. Trans. , vol.33 , pp. 306
- Zelent, D.¹ Najafi, H.² Odili, S.³ Buettger, C.⁴ Weik-Collins, H.⁵ Li, C.⁶ Doliba, N.⁷ Grimsby, J.⁸ Matschinsky, F.M.⁹

8
- 84930540987
- M. C. T. Fyfe M. P. Procter Drugs Fut. 2009 34 641
- (2009) Drugs Fut. , vol.34 , pp. 641
- Fyfe, M.C.T.¹ Procter, M.P.²

9
- 67349139275
- F. M. Matschinsky Nat. Rev. Drug Discovery 2009 8 399
- (2009) Nat. Rev. Drug Discovery , vol.8 , pp. 399
- Matschinsky, F.M.¹

10
- 39049086785
- M. Coghlan B. Leighton Expert Opin. Invest. Drugs 2008 17 145
- (2008) Expert Opin. Invest. Drugs , vol.17 , pp. 145
- Coghlan, M.¹ Leighton, B.²

11
- 20144389644
- D. McKerrecher J. V. Allen S. Bowker S. Boyd P. W. R. Caulkett G. S. Currie C. D. Davies M. L. Fenwick H. Gaskin E. Grange R. B. Hargreaves B. R. Hayter R. James K. M. Johnson C. Johnstone C. D. Jones S. Lackie J. W. Rayner R. P. Walker Bioorg. Med. Chem. Lett. 2005 15 2103
- (2005) Bioorg. Med. Chem. Lett. , vol.15 , pp. 2103
- McKerrecher, D.¹ Allen, J.V.² Bowker, S.³ Boyd, S.⁴ Caulkett, P.W.R.⁵ Currie, G.S.⁶ Davies, C.D.⁷ Fenwick, M.L.⁸ Gaskin, H.⁹ Grange, E.¹⁰ Hargreaves, R.B.¹¹ Hayter, B.R.¹² James, R.¹³ Johnson, K.M.¹⁴ Johnstone, C.¹⁵ Jones, C.D.¹⁶ Lackie, S.¹⁷ Rayner, J.W.¹⁸ Walker, R.P.¹⁹

12
- 33645896147
- D. McKerrecher J. V. Allen P. W. R. Caulkett P. C. S. Donald M. L. Fenwick E. Grange K. M. Johnson C. Johnstone C. D. Jones J. W. Rayner R. P. Walker Bioorg. Med. Chem. Lett. 2006 16 2705
- (2006) Bioorg. Med. Chem. Lett. , vol.16 , pp. 2705
- McKerrecher, D.¹ Allen, J.V.² Caulkett, P.W.R.³ Donald, P.C.S.⁴ Fenwick, M.L.⁵ Grange, E.⁶ Johnson, K.M.⁷ Johnstone, C.⁸ Jones, C.D.⁹ Rayner, J.W.¹⁰ Walker, R.P.¹¹

13
- 79956067812
- K. G. Pike J. V. Allen P. W. R. Caulkett D. S. Clarke C. S. Donald M. L. Fenwick K. M. Johnson C. Johnstone D. McKerrecher J. W. Rayner R. P. Walker I. Wilson Bioorg. Med. Chem. Lett. 2011 21 3467
- (2011) Bioorg. Med. Chem. Lett. , vol.21 , pp. 3467
- Pike, K.G.¹ Allen, J.V.² Caulkett, P.W.R.³ Clarke, D.S.⁴ Donald, C.S.⁵ Fenwick, M.L.⁶ Johnson, K.M.⁷ Johnstone, C.⁸ McKerrecher, D.⁹ Rayner, J.W.¹⁰ Walker, R.P.¹¹ Wilson, I.¹²

14
- 33748989539
- G. Coope A. M. Atkinson C. Allott D. McKerrecher C. Johnstone K. G. Pike K. G. P. C Holme H. Vertigan D. Gill M. P. Coghlan Br. J. Pharmacol. 2006 149 328
- (2006) Br. J. Pharmacol. , vol.149 , pp. 328
- Coope, G.¹ Atkinson, A.M.² Allott, C.³ McKerrecher, D.⁴ Johnstone, C.⁵ Pike, K.G.⁶ Holme, K.G.P.C.⁷ Vertigan, H.⁸ Gill, D.⁹ Coghlan, M.P.¹⁰

15
- 0035121356
- G. E. Schulze R. J. Clay L. E. Mezza C. L. Bregman R. A. Buroker J. D. Frantz Toxicol. Sci. 2001 59 297
- (2001) Toxicol. Sci. , vol.59 , pp. 297
- Schulze, G.E.¹ Clay, R.J.² Mezza, L.E.³ Bregman, C.L.⁴ Buroker, R.A.⁵ Frantz, J.D.⁶

16
- 0027257997
- T. Lufkin D. Lohnes M. Mark A. Dierich P. Gorry M.-P. Gaub M. LeMeur P. Chambon Proc. Natl. Acad. Sci. U. S. A. 1993 90 7225
- (1993) Proc. Natl. Acad. Sci. U. S. A. , vol.90 , pp. 7225
- Lufkin, T.¹ Lohnes, D.² Mark, M.³ Dierich, A.⁴ Gorry, P.⁵ Gaub, M.-P.⁶ Lemeur, M.⁷ Chambon, P.⁸

17
- 0035039458
- G. Livera V. Rouiller-Fabre R. Habert Biol. Reprod. 2001 64 1307
- (2001) Biol. Reprod. , vol.64 , pp. 1307
- Livera, G.¹ Rouiller-Fabre, V.² Habert, R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.